{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:38:10Z","timestamp":1774413490421,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1918,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/jto.0b013e3181da36f4","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T10:22:57Z","timestamp":1280917377000},"page":"1416-1423","source":"Crossref","is-referenced-by-count":114,"title":["Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel\/Carboplatin for Advanced Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Alan","family":"Sandler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Dahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret M.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181da36f4_bib1","author":"Surveillance Epidemiology and End Results (SEER)"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib2","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiology, and End Results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib3","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with, bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib4","series-title":"Avastin (bevacizumab) [package insert]","year":"2007"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib5","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1200\/JCO.2004.11.022","article-title":"Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer","volume":"22","author":"Johnson","year":"2004","journal-title":"J Clin Oncol"},{"issue":"15 pt 2","key":"10.1097\/JTO.0b013e3181da36f4_bib6","doi-asserted-by":"crossref","first-page":"s4613","DOI":"10.1158\/1078-0432.CCR-07-0647","article-title":"Bevacizumab in non small cell lung cancer","volume":"13","author":"Sandler","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib7","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2008.17.2056","article-title":"First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?","volume":"26","author":"Einhorn","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.1986.4.1.14","article-title":"A randomized trial of, the four most active regimens for metastatic non-small-cell lung cancer","volume":"4","author":"Ruckdeschel","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib9","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(00)04644-4","article-title":"Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial","volume":"357","author":"Georgoulias","year":"2001","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib10","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-na\u00efve patients with advanced-stage non-small-cell lung cancer","volume":"28","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib11","first-page":"174","article-title":"NCI programs: project expands group studies to community oncologists. The Oncologist News Bulletin","volume":"5","year":"2000","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.104.009373","article-title":"Cellular and pharmacogenetics, foundation of synergistic interaction of pemetrexed and gemcitabine in human, non-small cell lung cancer cells","volume":"68","author":"Giovannetti","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cncr.22208","article-title":"Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase","volume":"107","author":"Ceppi","year":"2006","journal-title":"Cancer"},{"issue":"suppl","key":"10.1097\/JTO.0b013e3181da36f4_bib14","first-page":"15s","article-title":"Diagnostic reproducibility of squamous cell carcinoma (SC) in the era of histology-directed non-small cell lung cancer (NSCLC) chemotherapy: a large prospective study","volume":"27","author":"Grilley-Olson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181da36f4_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/JTO.0b013e3181b28fb9","article-title":"Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies","volume":"4","author":"Ignatius","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"suppl","key":"10.1097\/JTO.0b013e3181da36f4_bib16","article-title":"Preliminary treatment patterns and safety outcomes for non-small cell lung cancer (NSCLC) from ARIES, a bevacizumab treatment observational cohort study","volume":"26","author":"Lynch","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:12:30Z","timestamp":1591747950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415306183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1556086415306183"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181da36f4","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}